Trial intelligence / Profile preview

Itraconazole Pulse vs Terbinafine in Pediatric Tinea Capitis

NCT07068256Completed

Start
Apr 2025
Primary completion
Sep 2025
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, open-label trial of itraconazole in tinea capitis (2 arms). Primary endpoint: Fungus eradication at 9 weeks. Started Apr 2025; status: completed.

02

Drugs

itraconazole
03

Conditions

tinea capitis

Beyond the preview

Go deeper on NCT07068256.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07068256.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call